
Frontiers in Oncology, Год журнала: 2024, Номер 14
Опубликована: Окт. 10, 2024
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm in which all the patients has translocation (
Язык: Английский
Frontiers in Oncology, Год журнала: 2024, Номер 14
Опубликована: Окт. 10, 2024
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm in which all the patients has translocation (
Язык: Английский
Pathology - Research and Practice, Год журнала: 2024, Номер 256, С. 155257 - 155257
Опубликована: Март 13, 2024
Язык: Английский
Процитировано
9Biology, Год журнала: 2024, Номер 13(8), С. 638 - 638
Опубликована: Авг. 20, 2024
Depression, a significant mental health disorder, is under intense research scrutiny to uncover its molecular foundations. Epigenetics, which focuses on controlling gene expression without altering DNA sequences, offers promising avenues for innovative treatment. This review explores the pivotal role of epigenetics in depression, emphasizing two key aspects: (I) identifying epigenetic targets new antidepressants and (II) using personalized medicine based distinct profiles, highlighting potential focal points such as methylation, histone structure alterations, non-coding RNA molecules miRNAs. Variations methylation individuals with depression provide opportunities target genes that are associated neuroplasticity synaptic activity. Aberrant acetylation may indicate antidepressant strategies involve enzyme modifications. Modulating miRNA levels can reshape depression-linked expression. The second section discusses profiles. Analyzing these patterns could identify biomarkers treatment response susceptibility facilitating tailored treatments proactive care. Addressing ethical concerns regarding information, privacy stigmatization, crucial understanding biological basis depression. Therefore, researchers must consider issues when examining disorders. importance critical aspect modern medical research. These findings hold great novel medications treatments, would significantly improve patient outcomes, transform psychiatry. As progresses, it expected more complex aspects processes enhance our comprehension, increase effectiveness therapies.
Язык: Английский
Процитировано
8Functional & Integrative Genomics, Год журнала: 2025, Номер 25(1)
Опубликована: Янв. 17, 2025
Язык: Английский
Процитировано
1Non-coding RNA Research, Год журнала: 2024, Номер 9(4), С. 1222 - 1234
Опубликована: Май 20, 2024
Ferroptosis, a form of regulated cell death, has emerged as crucial process in diverse pathophysiological states, encompassing cancer, neurodegenerative ailments, and ischemia-reperfusion injury. The glutathione (GSH)-dependent lipid peroxidation pathway, chiefly governed by peroxidase 4 (GPX4), assumes an essential part driving ferroptosis. GPX4, the principal orchestrator ferroptosis, garnered significant attention across cardiovascular, neuroscience domains over past decade. Noteworthy investigations have elucidated indispensable functions ferroptosis numerous diseases, including tumorigenesis, wherein robust within cells can impede tumor advancement. Recent research underscored complex regulatory role non-coding RNAs (ncRNAs) regulating GSH-GPX4 network, thus influencing cellular susceptibility to This exhaustive review endeavors probe into multifaceted processes which ncRNAs control network Specifically, we delve miRNAs, lncRNAs, circRNAs GPX4 expression impacting Moreover, discuss clinical implications dysregulated interactions between several conditions, underscoring their capacity viable targets for therapeutic intervention. Additionally, explores emerging strategies aimed at targeting modulate pathway manipulate advantage. A comprehensive understanding these intricate networks furnishes insights innovative avenues diseases associated with perturbed thereby laying groundwork interventions ferroptosis-related pathological conditions.
Язык: Английский
Процитировано
8Frontiers in Molecular Biosciences, Год журнала: 2024, Номер 11
Опубликована: Июнь 3, 2024
Leading anti-tumour therapeutic strategies typically involve surgery and radiotherapy for locally advanced (non-metastatic) cancers, while hormone therapy, chemotherapy, molecular targeted therapy are the current treatment options metastatic cancer. Despite initially high sensitivity rate to anticancer therapies, a large number of patients develop resistance, leading poor prognosis. The mechanisms related drug resistance highly complex, long non-coding RNAs appear play crucial role in these processes. Among these, lncRNA homeobox transcript antisense intergenic RNA (HOTAIR), widely implicated cancer initiation progression, likewise plays significant resistance. It can modulate cell activities such as proliferation, apoptosis, hypoxia, autophagy, well epithelial-mesenchymal transition, thereby contributing development resistant tumour cells. In this manuscript, we describe different antitumor which HOTAIR is involved suggest its potential predictive biomarker management patients.
Язык: Английский
Процитировано
5Genes, Год журнала: 2025, Номер 16(2), С. 140 - 140
Опубликована: Янв. 24, 2025
Amidst the prevalent and notable characteristic of a hypoxic microenvironment present in majority solid tumors, burgeoning number studies have revealed significance noncoding RNAs (ncRNAs) tumor regions. The transcriptome cancers is highly heterogeneous, with transcripts playing crucial roles. Long (lncRNAs) circular (circRNAs) are two distinctive classes ncRNA that garnering increasing attention. Biologically, they possess intriguing properties significant regulatory functions. Clinically, as promising biomarkers therapeutic targets. Additionally, recent research has evaluated clinical applications these ncRNAs RNA-based treatments noninvasive liquid biopsies. This review provides comprehensive summary on lncRNAs circRNAs within microenvironment. Furthermore, cancer diagnosis treatment emphasized, which could pave way for development effective targeted therapies.
Язык: Английский
Процитировано
0Clinica Chimica Acta, Год журнала: 2025, Номер unknown, С. 120242 - 120242
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Gene, Год журнала: 2024, Номер 940, С. 149180 - 149180
Опубликована: Дек. 19, 2024
Язык: Английский
Процитировано
2Cancer Cell International, Год журнала: 2024, Номер 24(1)
Опубликована: Март 30, 2024
Язык: Английский
Процитировано
1Medical Oncology, Год журнала: 2024, Номер 41(12)
Опубликована: Ноя. 8, 2024
Язык: Английский
Процитировано
1